Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-139138
Filing Date
2024-12-20
Accepted
2024-12-20 17:15:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2025_defa_14a_notice__ac.htm DEFA14A 30997
2 GRAPHIC img243975296_0.jpg GRAPHIC 126194
3 GRAPHIC img243975296_1.jpg GRAPHIC 109355
  Complete submission text file 0000950170-24-139138.txt   356810
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-41827 | Film No.: 241568922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)